Clinical Trials Browser

Phase 2/3 × OTHER × sargramostim × Clear all

NCT00630565 2024-01-29

Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia

Phase 2/3 Terminated

12 enrolled 12 charts

Other hematologic neoplasm

Congenital Abnormalities, Leukemia